Evidence map›Paper›PMID 36993932›Full record

ReviewFrontiers in psychiatry2023

Review of factors resulting in systemic biases in the screening, assessment, and treatment of individuals at clinical high-risk for psychosis in the United States.

Miranda A Bridgwater, Emily Petti, Maksim Giljen, LeeAnn Akouri-Shan, Joseph S DeLuca, Pamela Rakhshan Rouhakhtar, Caroline Millar, Nicole R Karcher, Elizabeth A Martin, Jordan DeVylder and 5 more

Open access · goldFull text readReview
In one paragraph

Review in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 1 country.

Miranda A BridgwaterDepartment of Psychological Science, University of California, Irvine, Irvine, CA, United States.
Emily PettiDepartment of Psychological Science, University of California, Irvine, Irvine, CA, United States.
Maksim GiljenDepartment of Psychological Science, University of California, Irvine, Irvine, CA, United States.
LeeAnn Akouri-ShanDepartment of Psychology, University of Maryland, Baltimore County, Baltimore, MD, United States.
Joseph S DeLucaDepartment of Psychological and Brain Sciences, Fairfield University, Fairfield, CT, United States.
Pamela Rakhshan RouhakhtarDepartment of Psychology, University of Maryland, Baltimore County, Baltimore, MD, United States.
Caroline MillarDepartment of Psychology, University of Maryland, Baltimore County, Baltimore, MD, United States.
Nicole R KarcherDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.
Elizabeth A MartinDepartment of Psychological Science, University of California, Irvine, Irvine, CA, United States.
Jordan DeVylderGraduate School of Social Service, Fordham University, New York, NY, United States.
Deidre AnglinDepartment of Psychology, The City College of New York, New York, NY, United States.
Raquel WilliamsThrive Together OC, Orange, CA, United States.
Lauren M EllmanDepartment of Psychology and Neuroscience, Temple University, Philadelphia, PA, United States.
Vijay A MittalDepartment of Psychology, Northwestern University, Evanston, IL, United States.
Jason SchiffmanDepartment of Psychological Science, University of California, Irvine, Irvine, CA, United States.
University of California, Irvine · USUniversity of Maryland, Baltimore County · USCity College of New York · USFairfield University · USFordham University · USNorthwestern University · USTemple University · USThrive Together · USWashington University in St. Louis · US

Funding

Training the next generation of clinical neuroscientistsT32MH122394 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rene S. Kahn, ANTONIA S NEW · 2020 to 2026
$2.5M
1/3-Community Psychosis Risk Screening: An Instrument Development Study SupplementR01MH112613 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI ELLMAN, LAUREN M · 2017 to 2022
$1.8M
Administrative Supplement - 3/3: Community Psychology Risk Screening: An Instrument Development StudyR01MH112612 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI PITTS, STEVEN C, SCHIFFMAN, JASON E · 2017 to 2022
$1.3M
2/3 Community psychosis risk screening: An instrument development studyR01MH112545 · NIMH · NORTHWESTERN UNIVERSITY · PI MITTAL, VIJAY A · 2017 to 2021
$1.2M
NIMH NIH HHS R01 MH112545NIMH NIH HHS R01 MH112612NIMH NIH HHS R01 MH112613NIMH NIH HHS T32 MH122394
6 · The paper itself

Abstract

Background: Since its inception, research in the clinical high-risk (CHR) phase of psychosis has included identifying and exploring the impact of relevant socio-demographic factors. Employing a narrative review approach and highlighting work from the United States, sociocultural and contextual factors potentially affecting the screening, assessment, and service utilization of youth at CHR were reviewed from the current literature. Results: Existing literature suggests that contextual factors impact the predictive performance of widely used psychosis-risk screening tools and may introduce systemic bias and challenges to differential diagnosis in clinical assessment. Factors reviewed include racialized identity, discrimination, neighborhood context, trauma, immigration status, gender identity, sexual orientation, and age. Furthermore, racialized identity and traumatic experiences appear related to symptom severity and service utilization among this population. Conclusions: Collectively, a growing body of research from the United States and beyond suggests that considering context in psychosis-risk assessment can provide a more accurate appraisal of the nature of risk for psychosis, render more accurate results improving the field's prediction of conversion to psychosis, and enhance our understanding of psychosis-risk trajectories. More work is needed in the U.S. and across the globe to uncover how structural racism and systemic biases impact screening, assessment, treatment, and clinical and functional outcomes for those at CHR.

Indexed as

clinical high-riskpsychosisscreeningsocial determinantssystemic bias

Identifiers

PMID36993932
PMCPMC10040591
OpenAlexW4324087038

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.